Dmitry Karshtedt is quoted in MarketWatch regarding the patents on a key Allergan product, the dry eye medication Restasis.
"Allergan Has Made an Unorthodox Agreement with an American Indian Tribe to Fend Off Competition for Its Key Product"
September 8, 2017